Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Jae Eun | - |
dc.contributor.author | Lee, Dong Won | - |
dc.contributor.author | Seo, Soo Hong | - |
dc.contributor.author | Ahn, Hyo Hyun | - |
dc.contributor.author | Kye, Young Chul | - |
dc.date.accessioned | 2021-09-02T02:36:02Z | - |
dc.date.available | 2021-09-02T02:36:02Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2018-12 | - |
dc.identifier.issn | 1473-2130 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/71419 | - |
dc.description.abstract | Background Melasma is a common acquired facial pigmentary disorder that is resistant to various modalities of treatment. Recently, the low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser (QSNY) has emerged as the new gold standard of melasma treatment in Asia. Objective To evaluate the efficacy and safety of low-fluence 1064-nm QSNY in Asian patients with melasma. Methods Data of patients with melasma treated with low-fluence QSNY in the department of dermatology at the Korea University Anam Hospital were reviewed retrospectively. A 1064-nm QSNY with 8 mm spot size and fluence of 1.2-2.0 J/cm(2) at 10 Hz was used. The results were evaluated using the modified Melasma Area and Severity Index (mMASI) score and the physician's global assessment (PGA). Results A total of 40 Korean patients with Fitzpatrick skin type III to IV were included. Patients were treated for a median of 10 sessions at a median of 1-week intervals. The mean mMASI score decreased by 54.23% from a baseline of 3.19 +/- 2.64 to 1.46 +/- 1.06 after treatment. On PGA, 1 out of 40 patients (2.5%) showed excellent improvement, 14 (35%) good, 15 (37.5%) fair, 6 (15%) poor, and 4 (10%) no improvement. However, two patients showed mottled hypopigmentation and rebound hyperpigmentation. Conclusion Low-fluence 1064-nm QSNY appears to be a safe and effective treatment for Asian patients with melasma. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | 1,064 NM LASER | - |
dc.subject | ND/YAG LASER | - |
dc.subject | SELECTIVE PHOTOTHERMOLYSIS | - |
dc.subject | FACIAL MELASMA | - |
dc.subject | 1064-NM | - |
dc.subject | COMBINATION | - |
dc.subject | LESIONS | - |
dc.title | Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, Soo Hong | - |
dc.contributor.affiliatedAuthor | Ahn, Hyo Hyun | - |
dc.contributor.affiliatedAuthor | Kye, Young Chul | - |
dc.identifier.doi | 10.1111/jocd.12760 | - |
dc.identifier.scopusid | 2-s2.0-85054320006 | - |
dc.identifier.wosid | 000453381000018 | - |
dc.identifier.bibliographicCitation | JOURNAL OF COSMETIC DERMATOLOGY, v.17, no.6, pp.1053 - 1058 | - |
dc.relation.isPartOf | JOURNAL OF COSMETIC DERMATOLOGY | - |
dc.citation.title | JOURNAL OF COSMETIC DERMATOLOGY | - |
dc.citation.volume | 17 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1053 | - |
dc.citation.endPage | 1058 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.subject.keywordPlus | 1,064 NM LASER | - |
dc.subject.keywordPlus | ND/YAG LASER | - |
dc.subject.keywordPlus | SELECTIVE PHOTOTHERMOLYSIS | - |
dc.subject.keywordPlus | FACIAL MELASMA | - |
dc.subject.keywordPlus | 1064-NM | - |
dc.subject.keywordPlus | COMBINATION | - |
dc.subject.keywordPlus | LESIONS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.